Dextrose Injection Market: What are the future growth opportunities? | Prominent Key Players Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc

Increasing number of launches pertaining to novel dextrose injection products by key players in the market is expected to drive market growth. For instance in 2018, SteriMAx Inc., engaged in production, development, marketing and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1835

Major driver for growth of the dextrose injection market is the robust pipeline of drugs in clinical trials. For instance, in 2017, Tri service general hospital completed its 5% Dextrose injection phase 1 clinical trials. 5% dextrose injection is used to treat ulnar neuropathy (peripheral entrapment neuropathy) at elbow. Since 2017, Tri service general hospital reported to have 10% dextrose injection in phase 2 clinical trials. 10% dextrose injection is used to treat Carpal tunnel syndrome. Carpal tunnel syndrome causes pain, numbness, and tingling in the hands. It occurs when the media nerve is squeezed or compressed as it travels through the wrist.

Increasing prevalence of disease such as hypoglycemia is expected to increase the demand for dextrose injection, which in turn is expected to fuel market growth. According to a survey conducted by Center for Disease Prevention and Control (CDC), in 2016, more than 1.5 million people in U.S. have hypoglycemia.

Request for Table of Contents @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1835
North America dextrose injection market is expected to hold a dominant position in the global market due to the presence of key players and robust pipeline of products in the region. For instance in 2016, Chisel Peak Medical Clinic, completed phase 2 clinical trials of its 20% dextrose injection indicated for treatment of temporomandibular dysfunction. Temporomandibular dysfunction is a type of temporomandibular disorder that causes pain in jaw joint and also in the muscles that control the jaw movement.

Increasing number of launches pertaining to novel dextrose injection products is expected to fuel regional market growth. For instance, in 2016, Baxter International Inc. launched ready to use version of vancomycin injection. Vancomycin injection treats infections caused by strains of methicillin-resistant staphylococci.

Asia Pacific dextrose injection market is expected to witness significant growth due to various sports initiatives taken by the government. India has various schemes for sports such as ‘Khelo India’, National Sports Development Fund Scheme for promotion of sports among individuals suffering from disabilities. According to Khelo India Program, 1000 students will be selected annually and will be offered a sponsorship of 5 lakhs for 8 years. Such huge participation in sports is expected to boost the growth of global dextrose injection market. Athletes use Dextrose injection to treat a variety of ligament, muscle, tendon, and joint pains.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1835

Key players operating in the global dextrose injection market include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.